Table 3.
Controls (n = 20) | Patients (n = 37) | p | |
---|---|---|---|
LV-EF (%) | 65 ± 4 | 64 ± 10 | 0.84 |
LV-EDV (ml) | 109 ± 27 | 122 ± 41 | 0.38 |
LV-ESV (ml) | 38 ± 13 | 46 ± 31 | 0.49 |
LV-SV | 71 ± 15 | 76 ± 18 | 0.40 |
LV-EDD | 45 ± 5 | 48 ± 5 | 0.08 |
LA (cm2) | 20 ± 3 | 20 ± 5 | 0.84 |
IVS (mm) | 10 ± 2 | 10 ± 2 | 0.11 |
PA (mm) | 24 ± 4 | 25 ± 3 | 0.37 |
LV mass (g) | 85 ± 20 | 90 ± 25 | 0.67 |
LGE | - | 16 (43%) | |
epicardial | - | 5 (13%) | |
intramural | - | 7 (19%) | |
transmural | - | - | |
subendocardial | - | 4 (11%) | |
% LV mass | - | 6.8 ± 5 | |
Native T1 (ms) | 952 (923–960) | 988 (965–1017) | <0.001 |
Post-contrast T1 (ms) | 524 (500–529) | 488 (468–528) | 0.03 |
ECV (%) | 24.5 (23–25) | 27.5 (26–29) | <0.001 |
T2 (ms) | 49 (48–51) | 53 (51–55) | <0.001 |
All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume